Trypanosoma cruzi uses macropinocytosis as an additional entry pathway into mammalian host cell

E S Barrias1, L C Reignault, W De Souza

  • 1Laboratório de Ultraestrutura Celular Hertha Meyer, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro - Av. Carlos Chagas Filho, 373, Bloco G - subsolo, Cidade Universitária, Ilha do Fundão, Rio de Janeiro 21941-902, Brazil.

Microbes and Infection
|September 27, 2012
PubMed

Insights

Trypanosoma cruzi can invade host cells through macropinocytosis, a process typically used for solute uptake. Inhibitors of macropinocytosis blocked parasite entry, confirming this invasion pathway.

Area of Science:

  • Cell Biology
  • Infectious Diseases
  • Parasitology

Background:

  • Intracellular pathogens like Trypanosoma cruzi invade host cells through various mechanisms.
  • Macropinocytosis is an endocytic pathway for large solute uptake, but pathogens can exploit it for entry.

Purpose of the Study:

  • To investigate if Trypanosoma cruzi utilizes macropinocytosis for entry into peritoneal macrophages and LLC-MK2 epithelial cells.

Main Methods:

  • Utilized macropinocytosis inhibitors to block Trypanosoma cruzi internalization.
  • Employed immunofluorescence and field emission scanning electron microscopy.
  • Examined the localization of macropinocytosis-related proteins (Rabankyrin 5, tyrosine kinases, Pak1, actin) and parasite co-localization with endocytic markers.

Main Results:

  • Macropinocytosis inhibitors significantly blocked Trypanosoma cruzi entry.
  • Field emission scanning electron microscopy showed parasites attached to the host cell surface after inhibitor treatment.
  • Key proteins involved in macropinosome formation and actin microfilaments were found at parasite entry sites.
  • Co-localization of Trypanosoma cruzi with an endocytic fluid phase marker was observed.

Conclusions:

  • Trypanosoma cruzi employs multiple invasion mechanisms into host cells.
  • Macropinocytosis is identified as a viable pathway for Trypanosoma cruzi host cell entry.